Natrixam (Indapamide, Amlodipine Besilate)

Indapamide / Amlodipine besilate, the active ingredient in Natrixam, is a combination antihypertensive presented as a tablet for oral use. It treats hypertension in adult patients.

GNH USA supplies Natrixam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Natrixam is a combination antihypertensive that lowers elevated blood pressure through diuretic and vasodilatory actions.

Essential hypertension: reduces systolic and diastolic pressure in patients with primary high blood pressure. Isolated systolic hypertension: provides effective control of elevated systolic values, especially in older adults. Resistant hypertension (adjunct): used together with other agents when blood pressure remains uncontrolled.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Peripheral edema: swelling of the ankles or lower legs due to vasodilation. - Dizziness or light‑headedness: related to blood pressure lowering. - Flushing: transient warmth and redness of the skin. - Fatigue: general feeling of tiredness. - Palpitations: awareness of heartbeat changes.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Electrolyte imbalance: especially low potassium or sodium levels. - Angioedema: rapid swelling of face, lips, tongue, or throat. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Arrhythmias: irregular heart rhythms that may require medical attention. - Renal impairment: worsening kidney function, particularly in volume‑depleted patients.

Before initiating Natrixam, clinicians should assess patient history and monitor relevant parameters. - Blood pressure monitoring: check regularly to avoid excessive lowering. - Electrolyte assessment: evaluate sodium and potassium levels, especially with concomitant diuretics. - Renal and hepatic function: adjust use in patients with impaired kidney or liver function. - Elderly patients: start at lower doses and monitor for orthostatic hypotension. - Abrupt discontinuation: avoid sudden stop to prevent rebound hypertension. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Natrixam may interact with several drug classes; careful review is advised.

Major Interactions (Avoid): - Concomitant potent antihypertensives: risk of severe hypotension. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase amlodipine exposure. - Lithium: may raise lithium levels and toxicity. - NSAIDs: can blunt diuretic effect and affect renal function. - High‑dose potassium‑sparing diuretics: exacerbate hyperkalemia.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): reduce amlodipine efficacy. - Other diuretics: monitor electrolytes for additive effects. - Beta‑blockers: additive blood pressure lowering, watch for bradycardia. - ACE inhibitors or ARBs: increased risk of renal impairment and hyperkalemia. - Antidiabetic agents: may enhance hypoglycemic effect, require glucose monitoring.